EU Reports Highlight Urgency Of Rethinking Drug Investment And Procurement Reform

Medicines For Europe Has Called For Clearer Legal Guidance On Generic And Biosimilar Policies

 
• By Chloe Kent
  
Question mark of yellow stars against blue background
Medicines for Europe has urged the EU to rethink investment and reform procurement in favor of off-patent drugs • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography